valganciclovir and Lymphoma--Large-B-Cell--Diffuse

valganciclovir has been researched along with Lymphoma--Large-B-Cell--Diffuse* in 2 studies

Other Studies

2 other study(ies) available for valganciclovir and Lymphoma--Large-B-Cell--Diffuse

Article	Year
[Gastric cytomegalovirus infection in a patient with non-Hodgkin's lymphoma]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Ganciclovir; Gastroscopy; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Stomach; Stomach Ulcer; Valganciclovir; Vincristine	2015
[Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir]. Ugeskrift for laeger, 2010, Oct-18, Volume: 172, Issue:42 A 35-year-old female was diagnosed with a primary central nervous system posttransplant Epstein-Barr-virus-associated lymphoproliferative disorder three years after a renal transplantation. The histological diagnosis of the brain tumour was a diffuse large B-cell lymphoma. The patient had had diabetes mellitus for 28 years and was treated with four weekly doses of the monoclonal antibody rituximab, the antiviral drug ganciclovir and high-dose prednisolone, and the immune suppression was reduced. After four weeks of treatment, a control magnetic resonance image showed complete regression of the central nervous system lesion. Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antiviral Agents; Brain Neoplasms; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Rituximab; Treatment Outcome; Valganciclovir	2010

Article

Year

[Gastric cytomegalovirus infection in a patient with non-Hodgkin's lymphoma].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Ganciclovir; Gastroscopy; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Stomach; Stomach Ulcer; Valganciclovir; Vincristine

2015

[Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].

Ugeskrift for laeger, 2010, Oct-18, Volume: 172, Issue:42

A 35-year-old female was diagnosed with a primary central nervous system posttransplant Epstein-Barr-virus-associated lymphoproliferative disorder three years after a renal transplantation. The histological diagnosis of the brain tumour was a diffuse large B-cell lymphoma. The patient had had diabetes mellitus for 28 years and was treated with four weekly doses of the monoclonal antibody rituximab, the antiviral drug ganciclovir and high-dose prednisolone, and the immune suppression was reduced. After four weeks of treatment, a control magnetic resonance image showed complete regression of the central nervous system lesion.

Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antiviral Agents; Brain Neoplasms; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Rituximab; Treatment Outcome; Valganciclovir

2010